Chemoradiotherapy versus Radiotherapy Alone in Elderly Patients with Stage III Non-Small Cell Lung Cancer: A Systematic Review

被引：0
|
作者：
Dawe, David E. [1 ]
Christiansen, David [2 ]
Zarychanski, Ryan [1 ]
Abou-Setta, Ahmed [2 ]
Ellis, Peter M. [3 ]
Swaminath, Anand [3 ]
Rothney, Janet [2 ]
Rabbani, Rasheda [2 ]
Mahmud, Salah [2 ]
机构：
[1] CancerCare Manitoba, Winnipeg, MB, Canada
[2] Univ Manitoba, Winnipeg, MB, Canada
[3] McMaster Univ, Hamilton, ON, Canada
来源：
JOURNAL OF THORACIC ONCOLOGY | 2015年 / 10卷 / 09期
关键词：
Geriatric Oncology; Chemoradiotherapy; elderly; Systematic review;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
MINI07.02
引用
收藏
页码：S286 / S286
页数：1
相关论文
共 50 条
  • [21] Concurrent chemoradiotherapy for unresectable stage III non-small cell lung cancer
    Vokes, EE
    Crawford, J
    Bogart, J
    Socinski, MA
    Clamon, G
    Green, MR
    CLINICAL CANCER RESEARCH, 2005, 11 (13) : 5045S - 5050S
  • [22] Durvalumab after chemoradiotherapy in stage III non-small cell lung cancer
    Tomasini, Pascale
    Greillier, Laurent
    Boyer, Arnaud
    Jeanson, Arnaud
    Barlesi, Fabrice
    JOURNAL OF THORACIC DISEASE, 2018, 10 : S1032 - S1036
  • [23] Durvalumab After Chemoradiotherapy in Patients With Unresectable Stage III Non-Small Cell Lung Cancer
    Mooradian, Meghan J.
    Cai, Ling
    Wang, Alice
    Qiao, Yao
    Chander, Pratibha
    Whitaker, Ryan M.
    JAMA NETWORK OPEN, 2024, 7 (04) : e247542
  • [24] Pembrolizumab with radiotherapy versus pembrolizumab alone in non-small cell lung cancer: A systematic review and meta-analysis
    Wibowo, K.
    Budiputri, C. L.
    Chandra, A. I.
    Agus, A. M. C.
    Tancherla, A.
    Dharmaraja, F.
    Wijovi, F.
    Angelica, V.
    Kurniawan, A.
    ANNALS OF ONCOLOGY, 2024, 35 : S1627 - S1628
  • [25] Management of unresected stage III non-small cell lung cancer: A systematic review
    Okawara, Gordon
    Mackay, Jean A.
    Evans, William K.
    Ung, Yee C.
    JOURNAL OF THORACIC ONCOLOGY, 2006, 1 (04) : 377 - 393
  • [26] Association between intensity modulated radiotherapy and survival in patients with stage III non-small cell lung cancer treated with chemoradiotherapy
    Koshy, Matthew
    Malik, Renuka
    Spiotto, Michael
    Mahmood, Usama
    Rusthoven, Chad G.
    Sher, David J.
    LUNG CANCER, 2017, 108 : 222 - 227
  • [27] Phase II trial of erlotinib and radiotherapy following chemoradiotherapy for patients with stage III non-small cell lung cancer.
    Komaki, R.
    Blumenschein, G. R.
    Wistuba, I. I.
    Lee, J. J.
    Allen, P.
    Wei, X.
    Welsh, J.
    O'Reilly, M.
    Herbst, R. S.
    Tang, X.
    Meyn, R.
    Liu, D.
    Hong, W. K.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [28] Influence of Comorbidities on the Efficacy of Radiotherapy with or without Chemotherapy in Elderly Stage III Non-small Cell Lung Cancer Patients
    Lee, Joo Ho
    Wu, Hong-Gyun
    Kim, Hak Jae
    Kim, Dong-Wan
    Lee, Se-Hoon
    Kim, Tae Min
    Kim, Young Whan
    Heo, Dae Seog
    CANCER RESEARCH AND TREATMENT, 2012, 44 (04): : 242 - 250
  • [29] EFFICACY AND SAFETY OF CONCURRENT CHEMORADIOTHERAPY IN ELDERLY PATIENTS WITH UNRESECTABLE STAGE III NON-SMALL CELL LUNG CANCER: A RETROSPECTIVE STUDY
    Boku, Shogen
    Kasamatsu, Yu
    Yoshinoya, Kiyokazu
    Kida, Takashi
    Izumi, Hiroyuki
    Ushijima, Yo
    Kasamatsu, Yoshihiro
    JOURNAL OF THORACIC ONCOLOGY, 2012, 7 (11) : S487 - S487
  • [30] Oral vinorelbine-based concomitant chemoradiotherapy in unresectable stage III non-small cell lung cancer: a systematic review
    Lesueur, Paul
    Martel-Laffay, Isabelle
    Escande, Alexandre
    Kissel, Manon
    Locher, Chrystel
    Gervais, Radj
    Schott, Roland
    Vergnenegre, Alain
    Chouaid, Christos
    EXPERT REVIEW OF ANTICANCER THERAPY, 2018, 18 (11) : 1159 - 1165
12345